Microbot Medical (MBOT) Change in Accured Expenses (2010 - 2026)

Microbot Medical has reported Change in Accured Expenses for 17 years, with the latest figure at $384000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 162.24% year-over-year to $384000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 136.71% YoY), and the FY2025 full-year result was $495000.0, down 43.3% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $384000.0, down from $506000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.0 million in Q4 2024, with the low at -$900000.0 in Q1 2023.
• Historically, Change in Accured Expenses has averaged $48705.9 across 5 years, with a median of $55000.0 in 2023.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 1920.0% — and 2025, when it soared 6545.45%.
• Microbot Medical's Change in Accured Expenses stood at $416000.0 in 2022, then sank by 86.78% to $55000.0 in 2023, then soared by 1807.27% to $1.0 million in 2024, then sank by 51.76% to $506000.0 in 2025, then declined by 24.11% to $384000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $384000.0 (Q1 2026), $506000.0 (Q4 2025), and -$103000.0 (Q3 2025), per Business Quant data.